| HOME >> BIOLOGY >> TECHNOLOGY |
Pre-Clinical Trial Expenses and Research Collaborations
2007 2006
$ $
-------------------------------------------------------------------------
Research collaboration expenses 293,785 252,460
Pre-clinical trial expenses - 48,705
-------------------------------------------------------------------------
Pre-clinical trial expenses and
research collaborations 293,785 301,165
-------------------------------------------------------------------------
-------------------------------------------------------------------------
During the third quarter of 2007, our research collaboration expenses were $293,785 compared to $252,460 for the third quarter of 2006. Our research collaboration activity continues to focus on the interaction of the immune system and the reovirus, the use of the reovirus as a co-therapy with existing chemotherapeutics, and to investigate new uses of the reovirus as a therapeutic.
Other Research and Development Expenses
2007 2006
$ $
-------------------------------------------------------------------------
R&D consulting fees 38,152 70,323
R&D salaries and benefits 342,155 299,224
Other R&D expenses 58,440 86,883
-----------------
'/>"/>
| SOURCE Oncolytics Biotech Inc. Copyright©2007 PR Newswire. All rights reserved |